Kayla Amodeo

Kayla Amodeo serves as a key subject-matter expert on Medicare Part B policy-related issues impacting the pharmaceutical industry, physicians, the federal government, and other stakeholders.

She supports clients with health policy research and analysis that spans a variety of therapeutic areas. Specifically, she provides clients business and advocacy strategies to solve complex issues related to legislative and regulatory policy.

Prior to joining Avalere, Kayla was the director of regulatory affairs at the American College of Rheumatology, where she provided expertise and guidance on issues impacting provider reimbursement and patients access to care. Kayla also previously worked for the Arthritis Foundation as the legislative research manager for the Advocacy and Access division and with Anthem in the Disease Management Program.

Kayla has a PhD in health education and promotion from the University of Alabama, an MA in health education, and a BS in public health from East Carolina University.

Authored Content

ICER is eager to position itself as the primary comparative and cost-effectiveness research body in the US. While their activity has been traditionally more limited to product-specific reviews, the Institute is increasingly looking to shape the broader debate around value and drug pricing.